Satellite Banner
Next Gen Sequencing
Scientific Community
Become a Member | Sign in
Home>News>This Article

A Snapshot of the NGS Market — User Views

Published: Wednesday, August 21, 2013
Last Updated: Wednesday, August 21, 2013
Bookmark and Share
Oxford Gene Technology has released the results from a recent survey of researchers using next generation sequencing.

The survey was designed to investigate current trends in NGS usage and determine future demands; to aid Oxford Gene Technology (OGT) in continuing to deliver high-quality, up-to-date services and provide insightful, relevant customer resources. The company received 596 responses from its worldwide database of contacts and donated to the UK charity DEBRA (for the genetic skin blistering condition Epidermolysis Bullosa) for each completed survey.

Responses on the most popular research areas for NGS and choice of methods uncovered a trend towards cost-effective, high-resolution targeted resequencing techniques over whole genome sequencing, with the Illumina platform identified as the leading technology. Cancer and rare disease are the most popular research areas for using NGS, supporting the use of targeted approaches which enable more accurate detection of rare variants.

Challenges in bioinformatics were found to be one of the biggest barriers to NGS implementation, which may explain why over a third of investigators choose to outsource data analysis. Supporting this finding, data quality and bioinformatics expertise are cited in the top three essential factors when choosing an NGS service provider. 

Further insights into the use of NGS for clinical tests, preferred NGS methods, and demands on service providers are also presented. Download the full results here.

The survey adds to a growing portfolio of informative resources from OGT on NGS, including a recent whitepaper on choosing the right NGS method and a free-to-download demo version of their innovative and easy to use Genefficiency™ NGS reporting software.

Download the survey results or see below for more information on OGT’s Genefficiency services.

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,100+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

OGT Announces Commercial and Financial Highlights for FY 2015
New products launched across all core brands; Cytocell® FISH, SureSeq™ NGS and CytoSure™ arrays for cancer and rare disease.
Saturday, December 12, 2015
OGT’s Popular ESHG Workshop Free to View Online
Learn about the next generation of microarrays in one of the best attended workshops of the conference.
Friday, July 17, 2015
Oxford Gene Technology Awarded £1.2m Genomics England Contract
Next Generation Sequencing analysis software will support 100,000 Genomes Project by providing intuitive reports for clinical interpretation.
Monday, March 16, 2015
The Role of NGS in Stratified Cancer Medicine
Clinical Scientists reveal the promise and considerations for next generation sequencing in stratified cancer medicine.
Thursday, March 05, 2015
OGT Announces Operational and Financial Highlights for FY 2014
OGT’s molecular genetics business delivers 54% growth in commercial revenues to £11.9m.
Tuesday, December 09, 2014
Pieces of the Puzzle - A Multi-method Approach to Tumour Profiling
OGT workshop provides insight on using complementary genomic technologies.
Friday, November 07, 2014
An Integrated Approach to Clinical Genetics Research
OGT’s new whitepaper explores the next stage of molecular testing.
Wednesday, April 09, 2014
OGT Announces Acquisition of Cytocell Ltd
Company expands leadership in genomic medicine.
Thursday, March 06, 2014
OGT Strengthens Focus on Cancer Biomarkers
Oxford Gene Technology announce the appointment of Dr Bob Holland as Chief Medical Officer.
Monday, October 21, 2013
OGT Awarded Best Medtech Dealmaker by Oxford Bioscience Network
Award recognizes OGT’s collaboration with Birmingham and Salisbury NHS Regional Genetics Laboratories.
Wednesday, October 09, 2013
OGT to Share Strategies for Reliable NGS Panel Assays
Live webinar will focus on enhanced bait design.
Thursday, September 19, 2013
Exploring the Next Generation of Cancer Genomics at BSGM
aCGH to NGS: OGT invites University of Oxford Professor to present latest research.
Thursday, September 12, 2013
New Whitepaper Compares Targeted Resequencing Strategies
OGT provides insight into choice of NGS methods.
Wednesday, July 17, 2013
OGT initiates Strategic Expansion with the Opening of New York Office
Oxford Gene Technology (OGT) announced that it has opened a new office in Tarrytown, New York to support and grow its CytoSure™ cytogenetics arrays and Genefficiency™ next generation sequencing business in the US.
Wednesday, November 21, 2012
OGT Releases New NGS Application Note Focusing on Results, Not Data
Obtaining rapid biological insight from complex NGS datasets.
Monday, August 06, 2012
Scientific News
Integrated Omics Analysis
Studying multi-omics promises to give a more holistic picture of the organism and its place in its ecosystem, however despite the complexities involved those within the field are optimistic.
Illumina Contributes to ClinVar Database
The contribution includes variants of all classifications, from pathogenic to benign, identified during interpretation of whole genome sequences generated in the CLIA-certified, CAP-accredited Illumina Clinical Services Laboratory.
Agilent Presents Early Career Professor Award to Dr. Roeland Verhaak
JAX professor recognized for the development and implementation of workflows for the analysis of big-data from transcriptomics to next generation sequencing approaches.
‘Poring Over’ DNA
Advancing nanopore sensing towards lower cost and more accurate DNA sequencing.
3D-Printing in Science: Conference Co-Staged with LABVOLUTION
LABVOLUTION 2017 will have an added highlight of a simultaneous conference, "3D-Printing in Science".
Know your Enemy
Genetic markers for mosquitos which prefer humans to cattle identified for improved malaria surveillance and control.
NASA's DNA Sequencing in Space is a Success
DNA has been sequenced in space for the first time ever for the Biomolecule Sequencer investigation, using the MinION sequencing device.
New Inflammatory Disease Discovered
NIH researchers have discovered a rare and potentially deadly disease - otulipenia - the mostly affects children.
Bringing NGS to the Crime Lab
New technology being validated in BCI lab for use in Ohio missing persons cases.
Expanding Knowledge of Viral Diversity
Environmental datasets help researchers double the number of microbial phyla known to be infected by viruses.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,100+ scientific videos